NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/12/2024
Voltar para busca
Dado oficial do USPTO
DRUG2DRUGS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
24/12/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42, 44
Data de depósito
23/08/2023
Data de registro
24/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/12/2024
Última transação
24/12/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
5
Tipo de titular
03
Localização do titular
Minato-ku, Tokyo, JP
Examinador
HUSSAIN, TASNEEM
Unidade examinadora
M90
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of The stylized wording "DRUG2DRUGS" with "DRUG2" in black and "DRUGS" in green.
Titulares e representantes
Titulares
F. C. (pessoa física)
Representantes
Suzanne M. Hengl BAKER BOTTS L.L.P.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical additives for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in scientific and biotechnological research and development
Classe 5
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Classe 42
Development of pharmaceutical preparations and medicines; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; Testing of pharmaceuticals; designdevelopment and research of chemicalspharmaceuticals and chemical compounds; consultancy and information services relating to designdevelopment and research of chemicalspharmaceuticals and chemical compounds; analysistesting and inspection of chemicalspharmaceuticals and chemical compounds; consultancy and information services relating to analysistesting and inspection of chemicalspharmaceuticals and chemical compounds; pharmaceutical drug development services; Technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; pharmaceutical research services; consulting services in the field of pharmaceutical research; testinginspection or research of pharmaceuticals; pharmaceutical research and development; research of molecule design; consultancy and information services relating to research of molecule design; scientific research and testing surveys in the nature of research on the subject of pharmaceuticalspharmaceutical research and development and pharmaceutical drug development services; providing computer programsproviding on-line non-downloadable software for designdevelopment and research of compounds which are a source of pharmaceuticals in the field of development of new drugs; designing of machinesapparatusinstruments or systems composed of such machinesapparatus and instruments; rental of laboratory apparatus and instruments
Classe 44
Providing medical information relating to diagnosticprevention and healing property of medicines; providing medical information relating to pharmaceuticals and compounds which is a source of pharmaceuticals; providing health information; dietary and nutritional guidance; rental of medical machines and apparatus; pharmaceutical compounding services
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
24/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/10/2024
PUBO
PUBLISHED FOR OPPOSITION
22/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2024
ALIE
ASSIGNED TO LIE
08/09/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/04/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/03/2024
GNSL
LETTER OF SUSPENSION E-MAILED
06/03/2024
CNSL
SUSPENSION LETTER WRITTEN
06/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/02/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/12/2023
GNRT
NON-FINAL ACTION E-MAILED
20/12/2023
CNRT
NON-FINAL ACTION WRITTEN
20/12/2023
DOCK
ASSIGNED TO EXAMINER
18/12/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/09/2023
NWAP
NEW APPLICATION ENTERED
26/08/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DRUG2DRUGS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.